← Evidence map

ReviewNature reviews. Clinical oncology2009

Are RAS mutations predictive markers of resistance to standard chemotherapy?

Yohann Loriot et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

35 papers cite it

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 19597509